Xuzhang Lu

696 total citations
54 papers, 477 citations indexed

About

Xuzhang Lu is a scholar working on Hematology, Molecular Biology and Immunology. According to data from OpenAlex, Xuzhang Lu has authored 54 papers receiving a total of 477 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Hematology, 21 papers in Molecular Biology and 21 papers in Immunology. Recurrent topics in Xuzhang Lu's work include Immune Cell Function and Interaction (18 papers), Acute Myeloid Leukemia Research (17 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (7 papers). Xuzhang Lu is often cited by papers focused on Immune Cell Function and Interaction (18 papers), Acute Myeloid Leukemia Research (17 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (7 papers). Xuzhang Lu collaborates with scholars based in China, Japan and Pakistan. Xuzhang Lu's co-authors include Shinji Nakao, J. Luis Espinoza, Hiroyuki Takamatsu, Yukio Kondo, Lingdi Ma, Zhichao Zhu, Hirohito Yamazaki, Chiharu Sugimori, Katsuya Okawa and Akiyoshi Takami and has published in prestigious journals such as Blood, The Journal of Immunology and Oncotarget.

In The Last Decade

Xuzhang Lu

47 papers receiving 469 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xuzhang Lu China 14 241 212 150 119 56 54 477
Keith Kerkof United States 7 191 0.8× 163 0.8× 138 0.9× 88 0.7× 80 1.4× 7 427
Ming Hou China 14 114 0.5× 216 1.0× 188 1.3× 70 0.6× 93 1.7× 31 461
Yoshitaka Kikukawa Japan 8 128 0.5× 104 0.5× 169 1.1× 143 1.2× 34 0.6× 20 405
Antonella Russo Rossi Italy 12 129 0.5× 151 0.7× 92 0.6× 93 0.8× 140 2.5× 23 384
Theo D. Kim United States 10 193 0.8× 220 1.0× 58 0.4× 109 0.9× 64 1.1× 13 423
Y Miura Japan 6 140 0.6× 134 0.6× 168 1.1× 199 1.7× 45 0.8× 10 448
Kazutaka Ozeki Japan 11 56 0.2× 242 1.1× 124 0.8× 76 0.6× 98 1.8× 42 385
C. H. Van Zantwijk Netherlands 13 75 0.3× 257 1.2× 258 1.7× 116 1.0× 60 1.1× 19 672
Julie A. Di Paolo United States 9 168 0.7× 116 0.5× 100 0.7× 134 1.1× 131 2.3× 17 521
Hyewon Lee South Korea 12 46 0.2× 220 1.0× 127 0.8× 150 1.3× 88 1.6× 38 424

Countries citing papers authored by Xuzhang Lu

Since Specialization
Citations

This map shows the geographic impact of Xuzhang Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuzhang Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuzhang Lu more than expected).

Fields of papers citing papers by Xuzhang Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xuzhang Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuzhang Lu. The network helps show where Xuzhang Lu may publish in the future.

Co-authorship network of co-authors of Xuzhang Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Xuzhang Lu. A scholar is included among the top collaborators of Xuzhang Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xuzhang Lu. Xuzhang Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Weiya, Mei‐Yu Chen, Jie Liu, et al.. (2025). Glofitamab induces deep and rapid response in relapsed primary central nervous system lymphoma. Leukemia & lymphoma. 66(8). 1475–1480.
2.
Li, Jin, et al.. (2024). Activated interferon response from DNA damage in multiple myeloma cells contributes to the chemotherapeutic effects of anthracyclines. Frontiers in Oncology. 14. 1357996–1357996. 1 indexed citations
3.
4.
5.
Chen, Mei‐Yu, et al.. (2023). A novel prognostic model of methylation-associated genes in acute myeloid leukemia. Clinical & Translational Oncology. 25(6). 1719–1728. 1 indexed citations
6.
Qin, Wei, et al.. (2022). PTPN11 mutations in adult acute myeloid leukaemia: Prevalence and clinical implications in the context of NPM1 mutation. Leukemia Research. 118. 106859–106859. 3 indexed citations
7.
He, Jinyuan, et al.. (2022). Companion gene mutations and their clinical significance in AML with double or single mutant CEBPA. International Journal of Hematology. 116(1). 71–80. 3 indexed citations
8.
Hua, Haiying, et al.. (2021). Mutational landscape of chronic myelomonocytic leukemia and its potential clinical significance. International Journal of Hematology. 115(1). 21–32. 4 indexed citations
9.
Chen, Mei‐Yu, et al.. (2021). Combination of Gemcitabine and Thymosin alpha 1 exhibit a better anti-tumor effect on nasal natural killer/T-cell lymphoma. International Immunopharmacology. 98. 107829–107829. 8 indexed citations
10.
Zhu, Zhichao, Yu Bai, Xuzhang Lu, & Chunjian Qi. (2020). [Effects and Mechanism of PARP Inhibitor Olaparib on the Expression of NKG2D Ligands in HL-60 Cells].. PubMed. 28(6). 1826–1830. 3 indexed citations
11.
Cai, Xiaohui, Rong Xiao, Xiuwen Zhang, et al.. (2018). [Mechanism of NKG2D ligands-mediated immune escape of adriamycin resistant leukemia K562/A02 cells].. PubMed. 39(3). 251–254.
12.
Lu, Xuzhang, et al.. (2017). Role of NKG2D in cytokine-induced killer cells against lung cancer. Oncology Letters. 13(5). 3139–3143. 6 indexed citations
13.
14.
Cai, Xiaohui, Xuzhang Lu, Xiuwen Zhang, et al.. (2015). STAT3 contributes to NK cell recognition by modulating expression of NKG2D ligands in adriamycin-resistant K562/AO2 cells. International Journal of Hematology. 102(5). 536–543. 8 indexed citations
15.
Ma, Lingdi, Xuzhang Lu, Zhichao Zhu, et al.. (2013). [Effects of matrine on the expression of NKG2D ligands in leukemia cells].. PubMed. 21(6). 1429–34. 1 indexed citations
16.
Lu, Xuzhang, Xiaohui Cai, Lingdi Ma, et al.. (2012). Role of NKG2D in cytokine-induced killer cells against multiple myeloma cells. Cancer Biology & Therapy. 13(8). 623–629. 16 indexed citations
17.
Takamatsu, Hiroyuki, J. Luis Espinoza, Xuzhang Lu, et al.. (2010). Autoantibodies specific to hnRNP K: a new diagnostic marker for immune pathophysiology in aplastic anemia. Annals of Hematology. 89(12). 1255–1263. 17 indexed citations
18.
Takamatsu, Hiroyuki, et al.. (2009). Anti-Moesin Antibodies in the Serum of Patients with Aplastic Anemia Stimulate Peripheral Blood Mononuclear Cells to Secrete TNF-α and IFN-γ. The Journal of Immunology. 182(1). 703–710. 32 indexed citations
19.
20.
Sugimori, Chiharu, Xingmin Feng, Xuzhang Lu, et al.. (2006). Small Populations of PNH-Type Cells in Aplastic Anemia Patients Are Derived from PIG-A Mutant Stem Cell Clones without Proliferative Advantage.. Blood. 108(11). 974–974. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Keith Kerkof Breakdown of academic impact, for papers by Ming Hou Breakdown of academic impact, for papers by Yoshitaka Kikukawa Breakdown of academic impact, for papers by Antonella Russo Rossi Breakdown of academic impact, for papers by Theo D. Kim Breakdown of academic impact, for papers by Y Miura Breakdown of academic impact, for papers by Kazutaka Ozeki Breakdown of academic impact, for papers by C. H. Van Zantwijk Breakdown of academic impact, for papers by Julie A. Di Paolo Breakdown of academic impact, for papers by Hyewon Lee
Rankless by CCL
2026